---
schema_version: "secwatch.filing_event.v1"
accession: "0000010795-22-000059"
form_type: "8-K"
ticker: "BDX"
cik: "0000010795"
company_name: "BECTON DICKINSON & CO"
filed_at: "2022-08-25T23:59:59+00:00"
generated_at: "2026-06-23T21:14:31.873079+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# BD appoints Garrison as Medical segment president and Byrd as Interventional segment president; Campion departs

## Summary
- Michael Garrison named EVP & President, Medical segment, effective Sept 6, 2022; previously led Medication Management Solutions.
- Richard Byrd named EVP & President, Interventional segment, effective Sept 6, 2022; previously led Medication Delivery Solutions.
- Simon Campion to depart BD on Sept 9, 2022 for executive role elsewhere; he joined via C.R. Bard acquisition.
- Both Garrison and Byrd report to CEO Tom Polen and join Executive Leadership Team.

## SEC filing metadata
- accession: 0000010795-22-000059
- form_type: 8-K
- ticker: BDX
- cik: 0000010795
- company_name: BECTON DICKINSON & CO
- filed_at: 2022-08-25T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/10795/000001079522000059/0000010795-22-000059-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/10795/000001079522000059/bdx-20220822.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000010795-22-000059
- JSON: https://secwatch.observer/filing/0000010795-22-000059.json
- Plain text: https://secwatch.observer/filing/0000010795-22-000059.txt

## Key facts
- Executive change
  Michael Garrison was named as Executive Vice President and President, Medical Segment at BECTON DICKINSON & CO.
  - Action: named
  - Role: Executive Vice President and President, Medical Segment
  source text: Michael Garrison has been named BD's Executive Vice President and President, Medical Segment
  evidence_url: https://www.sec.gov/Archives/edgar/data/10795/000001079522000059/0000010795-22-000059-index.htm
- Executive change
  Richard Byrd was named as Executive Vice President and President, Interventional Segment at BECTON DICKINSON & CO.
  - Action: named
  - Role: Executive Vice President and President, Interventional Segment
  source text: Richard Byrd has been named BD's Executive Vice President and President, Interventional Segment
  evidence_url: https://www.sec.gov/Archives/edgar/data/10795/000001079522000059/0000010795-22-000059-index.htm
- Executive change
  Simon Campion departed as Executive Vice President and President, Medical Segment at BECTON DICKINSON & CO.
  - Action: departed
  - Role: Executive Vice President and President, Medical Segment
  source text: Simon Campion informed BD that he will depart BD on September 9, 2022 for an executive role in the health care industry.
  evidence_url: https://www.sec.gov/Archives/edgar/data/10795/000001079522000059/0000010795-22-000059-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.